Publikationen im NUM

Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.

Nordsiek F, Bodenschatz E, Bagheri G, et al . Risk assessment for airborne disease transmission by poly-pathogen aerosols. PLOS ONE. 2021;      [DOI] 
Wunsch M, Aschemeier D, Hegera E, et al . Safe and effective pool testing for SARS-CoV-2 detection. J Clin Virol. 2021; 145      [DOI] 
Reis S, Popp M, Schmid B, Stegemann M, Metzendorf M, Kranke P, Meybohm P, Weibel S. Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2021; 11(1):57.      [DOI] 
Hillus D, et al . Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. The Lancet Respiratory Medicine. 2021;      [DOI] 
Möckel M, Corman VM, Stegemann MS, et al . SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarker. 2021; 26(3):      [DOI] 
Deinhardt-Emmer S, Bottcher S, Haring C, Giebeler L, Henke A, Zell ea. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol. 2021;
Wendisch D, Dietrich O, Mari T, Stillfried S, Ibarra IL, Mittermaier ea. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021; 1846243—6261.e6227.      [DOI] 
Wendisch D, Dietrich O, Mari T, Stillfried S, Ibarra I, Mittermaier M, Mache C, Chua R, Knoll R, Timm S, others . SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021; 184(26):6243—6261.e27.      [DOI] 
Wendisch D, et al . SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021; 1846243-6261.e27.      [DOI] 
Wendisch D, Dietrich O, Mari T, et al . SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;      [DOI] 
Jansen J, Reimer K, Nagai J, et al . SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2021;      [DOI] 
Hoffmann M, et al . SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization. Cell Reports. 2021; 35109017.      [DOI] 
Malin JJ, et al . SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma. Blood advances. 2021;      [DOI] 
Schwarz T, et al . SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Frontiers in immunology. 2021; 12629185.      [DOI] 
Stillfried S, Villwock S, Bülow RD, Djudjaj S, Buhl EM, Maurer A, Ortiz-Brüchle N, Celec P, Klinkhammer BM, Wong DW, Cacchi C, Braunschweig T, Knüchel-Clarke R, Dahl E, Boor P. SARS-CoV-2 RNA screening in routine pathology specimens. Microb Biotechnol. 2021 Jul.; 14(4):1627-1641.      [DOI] 
Heinemann S, Bludau A, Kaba H, et al . SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST. GMS Hyg Infect Control. 2021; 16      [DOI] 
Heinemann S, Bludau A, Kaba H, Knolle P, Grundmann H, Scheithauer S. SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST. GMS hygiene and infection control. 2021; 16Doc31.      [DOI] 
Hoffmann M, et al . SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Reports. 2021; 36109415.      [DOI] 
Hoffmann M, et al . SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021; 1842384-2393.e12.      [DOI] 
Lohner L, Fröb D, Edler C, Schröder AS, Dietz E, Ondruschka B. SARS-CoV-2-assoziierte Todesfälle von erwachsenen Personen bis 50 Jahre: Eine retrospektive Auswertung der COVID-19-assoziierten Todesfälle im Jahr 2020 im Institut für Rechtsmedizin Hamburg, Deutschland [SARS-CoV-2-associated deaths in adult persons up to 50 years of age]. Rechtsmedizin (Berl). 2021; 1-9.
Gassen N, Papies J, Bajaj T, Emanuel J, Dethloff F, Chua ea. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021; 123818.
Kreuzberger N, et al . SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database of Systematic Reviews. 2021; 9CD013825.      [DOI] 
Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021; 9(9):CD013825.      [DOI] 
Hirsch C, et al . SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database of Systematic Reviews. 2021;      [DOI] 
Schmidt KG, et al . SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses. Frontiers in immunology. 2021; 12627568.      [DOI] 
Gornyk D, et al . SARS-CoV-2-Seroprävalenz in Deutschland. Eine bevölkerungsbezogene sequenzielle Studie in sieben Regionen. Dtsch Arztebl Int. 2021; 118824–831.
Klein A, Langenwalder F, Heinrich F, Meißner K, Schröder AS, Püschel K, Ondruschka B, Lütgehetmann M, Heinemann A. SARS-CoV2-Zufallsentdeckungen bei Hamburger Todesfällen: ein epidemiologisches Monitoring während des dynamischen Infektionsgeschehens im Frühjahr 2020 [SARS-CoV2 incidental findings among Hamburg deaths: an epidemiological monitoring during the dynamic infection event in spring 2020]. Rechtsmedizin (Berl). 2021; 1-7.
Adams ER, Wolday D, Denkinger CM, et al . Scaled testing for COVID-19 needs community involvement. J Glob Health. 2021; 11      [DOI]      [Datei] 
Würstle S, Spinner CD, Voit F, et al . Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection. 2021; 49(5):      [DOI] 
Würstle S, Spinner C, Voit F, others . Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection. 2021; 49(5):      [DOI]      [Datei] 
Schmuck J, Hiebel N, Rabe M, Schneider J, Erim Y, Morawa E, Jerg-Bretzke L, Beschoner P, Albus C, Hannemann J, Weidner K, Steudte-Schmiedgen S, Radbruch L, Brunsch H, Geiser F. Sense of coherence, social support and religiosity as resources for medical personnel during the COVID-19 pandemic: A web-based survey among 4324 health care workers within the German Network University Medicine. PLOS ONE. 2021; 16(7):      [DOI] 
Steinbeis F, Thibeault C, Doellinger F, Ring R, Mittermaier M, Ruwwe-Glösenkamp C, Alius F, Knape P, Meyer H, Lippert L, others . Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med. 2021; 191106709.      [DOI] 
Günl F, Mecate-Zambrano A, Rehländer S, Hinse S, Ludwig S, Brunotte L. Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development. Vaccines (Basel). 2021; 9
Holz J. Singapurs gebrochenes Versprechen. Südostasien. Zeitschrift für Politik, Kultur, Dialog. 2021 Feb.;
Fischer DS, et al . Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'. Nature Communications. 2021; 124515.      [DOI] 
Wulff A, Baier C, Marschollek M, et al . SmICS: Eine smarte Lösung zur automatisierten Ausbruchserkennung im Krankenhaus. Gesundhyte. 2021; 14     [Datei] 
Schug C, Morawa E, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Steudte-Schmiedgen S, Borho A, Lieb M, Erim Y. Social Support and Optimism as Protective Factors for Mental Health among 7765 Healthcare Workers in Germany during the COVID-19 Pandemic: Results of the VOICE Study. International Journal of Environmental Research and Public Health. 2021; 18(7):      [DOI]      [Datei] 
Dragano N, Hoebel J, Wachtler B, Diercke M, Lunau T, Wahrendorf M. Soziale Ungleichheit in der regionalen Ausbreitung von SARS-CoV-2. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2021; 641116—1124.      [DOI] 
Rubio-Acero R, Beyerl J, Muenchhoff M, Roth MS, Castelletti N, Paunovic I, Radon K, Springer B, Nagel C, Boehm B, Böhmer MM, Graf A, Blum H, Krebs S, Keppler OT, Osterman A, Khan ZN, Hoelscher M, Wieser A. Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience. The Science of the total environment. 2021; 797149031.      [DOI] 
Rubio-Acero R, Beyerl J, Muenchhoff M, et al . Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich: One year of experience. Sci Total Environ. 2021; 797      [DOI] 
Einhauser S, Peterhoff D, Niller HH, et al . Spectrum bias and individual strengths of SARS-CoV-2 serological tests—A population-based evaluation. Diagnostics. 2021; 11(10):      [DOI]      [Datei] 
Alvarez-Fischer D, Borsche M, Balck A, et al . Spreading of SARS-CoV-2 Among Adult Asylum Seekers in Refugee Shelters in Germany. Lancet. 2021;      [DOI] 
Geraedts M, Eberlein-Gonska M, Hecker R, Schneider K, Schroeder-Printzen I, Zeuner M. Stationäre Versorgung: Empfehlungen für ein künftiges Pandemiemanagement. Dtsch Arztebl International. 2021; 118(19—20):A-991.
Torres Reyes CR, Steinmann E, Timmesfeld N, et al . Students in Dormitories were not major drivers of the pandemic during winter term 2020/2021: A cohort study with RT-PCR and antibody surveillance in a German university city. COVID. 2021; 1(1):      [DOI] 
Warnat-Herresthal S, et al . Swarm Learning for decentralized and confidential clinical machine learning. Nature. 2021;      [DOI] 
Hempel T, et al . Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties. Chemical Science. 2021; 1212600–12609.      [DOI] 
Wagner C, Griesel M, Mikolajewska A, Mueller A, Nothacker M, Kley K, Metzendorf M, Fischer A, Kopp M, Stegemann M, Skoetz N, Fichtner F. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database of Systematic Reviews. 2021; 2021CD014963.      [DOI] 
O'Hare M, Amarnani D, Whitmore HAB, An M, Marino C, Ramos L, Delgado-Tirado S, Hu X, Chmielewska N, Chandrahas A, others . Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators. Am J Pathol. 2021; 191(7):1193-1208.      [DOI] 
Baldinger M, Heinrich A, Adams T, Martens E, Dommasch M, Muller A, Siegmann A, Schmidt G, Amft O, Laerhoven KV. TELECOVID: Remote Vital Signs Monitoring of COVID-19 Risk Patients in Home Isolation With an In-Ear Wearable. IEEE Pervasive Computing. 2021; 20(2):58—62.      [DOI] 
Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, others . Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021; 12(1):4869.      [DOI]